| Primary |
| Pain |
24.1% |
| Product Used For Unknown Indication |
21.3% |
| Drug Use For Unknown Indication |
16.7% |
| Back Pain |
7.7% |
| Depression |
3.7% |
| Diabetes Mellitus |
3.7% |
| Neuropathy Peripheral |
3.4% |
| Hypertension |
3.1% |
| Pain In Extremity |
2.2% |
| Anxiety |
1.9% |
| Insomnia |
1.9% |
| Cancer Pain |
1.5% |
| Arthritis |
1.2% |
| Blood Pressure |
1.2% |
| Breakthrough Pain |
1.2% |
| Nausea |
1.2% |
| Restless Legs Syndrome |
1.2% |
| Abdominal Pain |
0.9% |
| Arthralgia |
0.9% |
| Depressive Symptom |
0.9% |
|
| Unresponsive To Stimuli |
12.8% |
| Overdose |
11.6% |
| Vomiting |
11.6% |
| Product Quality Issue |
7.0% |
| Toxicity To Various Agents |
7.0% |
| Drug Ineffective |
5.8% |
| Death |
4.7% |
| Drug Level Increased |
4.7% |
| Malaise |
3.5% |
| Product Substitution Issue |
3.5% |
| Swelling Face |
3.5% |
| Vision Blurred |
3.5% |
| Weight Decreased |
3.5% |
| Withdrawal Syndrome |
3.5% |
| Accidental Overdose |
2.3% |
| Confusional State |
2.3% |
| Crying |
2.3% |
| Fatigue |
2.3% |
| Feeling Abnormal |
2.3% |
| Respiratory Depression |
2.3% |
|
| Secondary |
| Pain |
15.3% |
| Product Used For Unknown Indication |
13.1% |
| Back Pain |
11.4% |
| Drug Use For Unknown Indication |
9.6% |
| Spinal Column Stenosis |
5.1% |
| Intervertebral Disc Degeneration |
4.8% |
| Depression |
4.6% |
| Neuropathy Peripheral |
4.4% |
| Diabetes Mellitus |
4.2% |
| Insomnia |
4.2% |
| Osteoarthritis |
3.9% |
| Anxiety |
3.5% |
| Neuralgia |
2.8% |
| Breakthrough Pain |
2.6% |
| Pain In Extremity |
2.4% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Rhinorrhoea |
1.8% |
| Thyroid Disorder |
1.7% |
| Blood Pressure |
1.5% |
| Cancer Pain |
1.5% |
|
| Constipation |
10.1% |
| Malaise |
10.1% |
| Overdose |
8.7% |
| Chest Pain |
7.2% |
| Unresponsive To Stimuli |
7.2% |
| Vomiting |
7.2% |
| Weight Decreased |
5.8% |
| Withdrawal Syndrome |
5.8% |
| Drug Ineffective |
4.3% |
| Tibia Fracture |
4.3% |
| Application Site Bleeding |
2.9% |
| Application Site Pruritus |
2.9% |
| Nausea |
2.9% |
| Postictal State |
2.9% |
| Rash |
2.9% |
| Respiratory Arrest |
2.9% |
| Somnolence |
2.9% |
| Swelling Face |
2.9% |
| Treatment Noncompliance |
2.9% |
| Tremor |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
28.6% |
| Diffuse Large B-cell Lymphoma |
14.3% |
| Nuclear Magnetic Resonance Imaging |
11.9% |
| Analgesic Therapy |
9.5% |
| Chronic Obstructive Pulmonary Disease |
7.1% |
| Blood Cholesterol Increased |
3.6% |
| Anxiety |
2.4% |
| Back Pain |
2.4% |
| Gastrointestinal Disorder |
2.4% |
| Hypertension |
2.4% |
| Lung Disorder |
2.4% |
| Non-small Cell Lung Cancer |
2.4% |
| Pain |
2.4% |
| Anticoagulant Therapy |
1.2% |
| Asthma |
1.2% |
| Bipolar Disorder |
1.2% |
| Blood Pressure |
1.2% |
| Cardiac Disorder |
1.2% |
| Cardiovascular Disorder |
1.2% |
| Haemorrhoids |
1.2% |
|
| Pain |
20.0% |
| Swelling |
20.0% |
| Dyspnoea |
10.0% |
| General Physical Health Deterioration |
10.0% |
| Mental Impairment |
10.0% |
| Splenomegaly |
10.0% |
| Transient Ischaemic Attack |
10.0% |
| Withdrawal Syndrome |
10.0% |
|
